Evidence map›Paper›PMID 38548172›Full record

ArticleThe journal of allergy and clinical immunology. In practice2024

Paradoxical bronchodilator response is associated with increased risk of asthma exacerbations.

Battoul Fakhry, Celine Chedraoui, Joelle Sleiman, Amy Attaway, Tara Carr, Benjamin Gaston, Bo Hu, Deborah Meyers, Victor E Ortega, Eugene R Bleecker and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Battoul FakhryLerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
Celine ChedraouiLerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
Joelle SleimanLerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
Amy AttawayLerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
Tara CarrDepartment of Medicine, University of Arizona, Tucson, Ariz.
Benjamin GastonDepartment of Pediatrics, Indiana University, Indianapolis, Ind.
Bo HuLerner Research Institute and Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
Deborah MeyersDepartment of Medicine, Mayo Clinic, Scottsdale, Ariz.
Victor E OrtegaDepartment of Medicine, Mayo Clinic, Scottsdale, Ariz.
Eugene R BleeckerDepartment of Medicine, Mayo Clinic, Scottsdale, Ariz.
Joe ZeinDepartment of Medicine, Mayo Clinic, Scottsdale, Ariz. Electronic address: Zein.Joe@mayo.edu.

Funding

S-nitrosylation signaling in asthmaP01HL158507 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHM, TIM · 2021 to 2025
$12.0M
The Impact of Biological Sex on Asthma OutcomesR01HL161674 · NHLBI · MAYO CLINIC ARIZONA · PI Joe Zein · 2023 to 2026
$1.5M
NHLBI NIH HHS P01 HL158507NHLBI NIH HHS R01 HL161674
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaBronchodilator AgentsAdultDisease ProgressionFemaleHumansMaleMiddle AgedRiskBronchodilator Agents

Identifiers

PMID38548172
PMCPMC11238764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.